Antibodies & Hybridomas — page 11 of 58
Antibodies & Hybridomas
Page 11 of 58
| Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
|---|---|---|---|---|---|---|---|---|
| SARS-CoV-2 S2 | monoclonal | Recombinant Human | SARS-CoV-2 | unconjugated | n/a | n/a |
 CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Nucleocapsid | monoclonal | Recombinant Rabbit | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Spike | RMD4 | Mouse | SARS-CoV-2 Spike | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike | polyclonal | Rabbit | sars coronavirus 2 | antigen affinity purified | 100 µl | n/a |
 GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike | polyclonal | Rabbit | sars coronavirus 2 | antigen affinity purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike RBD | HL1003 | Rabbit | sars coronavirus 2 | peroxidase (HRP) conjugate | 50 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike RBD | HL1003 | Rabbit | sars coronavirus 2 | Protein A purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike RBD | HL1004 | Rabbit | sars coronavirus 2 | Protein A purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike RBD | HL1014 | Rabbit | sars coronavirus 2 | Protein A purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike RBD | HL257 | Rabbit | sars coronavirus 2 | Protein A purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike RBD | polyclonal | Rabbit | sars coronavirus 2 | antigen affinity purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike RBD | polyclonal | Rabbit | sars coronavirus 2 | antigen affinity purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike S1 | HL1 | Rabbit | sars coronavirus 2 | Protein A purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike S1 | HL134 | Rabbit | sars coronavirus 2 | Protein A purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike S1 | HL13402 | Rabbit | sars coronavirus 2 | Protein A purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike S1 | HL263 | Rabbit | sars coronavirus 2 | Protein A purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike S1 | HL6 | Rabbit | sars coronavirus 2 | Protein A purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike S1 | GT263 | Mouse | sars coronavirus 2 | Protein G purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV-2 (COVID-19) Spike S1 | polyclonal | Rabbit | sars coronavirus 2 | antigen affinity purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| SARS-CoV / SARS-CoV-2 (COVID-19) spike | 1A9 | Mouse | sars coronavirus, sars coronavirus 2 | Protein G purified | 100 µl | n/a |
GENETEX INC. |
More Info |
| Orf1ab | polyclonal | Rabbit | n/a | unconjugated | 0.1 mg | n/a |
 BIORBYT LTD. |
More Info |
| SARS-CoV-2 Nucleocapsid (N) Protein | 7G9.C2 | Mouse | SARS-CoV-2 | Protein A purified | 100 µg | n/a |
 ROCKLAND IMMUNOCHEMICALS INC. |
More Info |
| SARS-CoV-2 Nucleocapsid (N) Protein | polyclonal | Rabbit | SARS-CoV-2 | immunoaffinity purified | 25 µL | n/a |
ROCKLAND IMMUNOCHEMICALS INC. |
More Info |
| SARS-CoV-2 Nucleocapsid (N) Protein | polyclonal | Rabbit | SARS-CoV-2 | immunoaffinity purified | 100 µg | n/a |
ROCKLAND IMMUNOCHEMICALS INC. |
More Info |
| SARS-CoV-2 Nucleocapsid (N) Protein | polyclonal | Rabbit | SARS-CoV-2 | biotin conjugate | 100 µg | n/a |
ROCKLAND IMMUNOCHEMICALS INC. |
More Info |
| SARS-CoV-2 Nucleocapsid (N) Protein | polyclonal | Rabbit | SARS-CoV-2 | Protein A purified | 500 µg | n/a |
ROCKLAND IMMUNOCHEMICALS INC. |
More Info |
| SARS-CoV-2 Nucleocapsid (N) Protein | polyclonal | Rabbit | SARS-CoV-2 | Protein A purified | 100 µg | n/a |
ROCKLAND IMMUNOCHEMICALS INC. |
More Info |
| SARS-CoV-2 | BF-1H7 | Mouse | n/a | Protein G purified | 100 µl | n/a |
 BIOFRONT TECHNOLOGIES |
More Info |
| SARS-CoV-2 | BF-2F3 | Mouse | n/a | Protein G purified | 100 µl | n/a |
BIOFRONT TECHNOLOGIES |
More Info |
| SARS-CoV-2 | BF-3G9 | Mouse | n/a | Protein G purified | 100 µl | n/a |
BIOFRONT TECHNOLOGIES |
More Info |
| SARS-CoV-2 Variants (Omicron) S | monoclonal | Recombinant Human | MERS, SARS-CoV, SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Spike NTD | monoclonal | Recombinant Human | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 Nucleocapsid Protein | 0004 | Rabbit | SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4), SARS-CoV, MERS-CoV; | unconjugated | 100 µL | n/a |
 CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 RBD (Bamlanivimab biosimilar) | monoclonal | Recombinant Human | human | Protein A/G purified | 100 µg, 1 mg, | n/a |
 ABBEXA LTD |
More Info |
| SARS-CoV-2 RBD (Cilgavimab biosimilar) | monoclonal | Recombinant Human | human | Protein A/G purified | 100 µg, 1 mg, | n/a |
ABBEXA LTD |
More Info |
| SARS-CoV-2 RBD (Tixagevimab biosimilar) | monoclonal | Recombinant Human | human | Protein A/G purified | 100 µg, 1 mg, | n/a |
ABBEXA LTD |
More Info |
| SARS-CoV-2 (COVID-19) ORF9B | polyclonal | Sheep | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 Spike | monoclonal | Recombinant Rabbit | SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
| SARS-CoV-2 S2 | polyclonal | Rabbit | n/a | unconjugated | 100 ul | n/a |
BIORBYT LTD. |
More Info |
| ORF10 | polyclonal | Sheep | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
| ORF6 | polyclonal | Sheep | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
| ORF8 | polyclonal | Sheep | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
| ORF1ab | polyclonal | Sheep | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
| ORF1ab | polyclonal | Sheep | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 004 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617), SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4); | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 004 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617), SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4); | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 08 | Mouse | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617), SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4); | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 08 | Mouse | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Delta (B.1.617), SARS-CoV-2 Delta (B.1.617.2), SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4); | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 019 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 100 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV/SARS-CoV-2 Nucleocapsid Protein | 019 | Rabbit | SARS-CoV, SARS-CoV-2, SARS-CoV-2 Omicron (B.1.1.529), SARS-CoV-2 Omicron (BA.2), SARS-CoV-2 Omicron XE (BA.1 x BA.2), SARS-CoV-2 Omicron (BA.4), SARS-CoV-2 Delta (B.1.617.2); | unconjugated | 50 µL | n/a |
CAYMAN CHEMICAL COMPANY |
More Info |